Labcorp (LH)
(Delayed Data from NYSE)
$209.49 USD
+2.40 (1.16%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $209.57 +0.08 (0.04%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth C Momentum C VGM
Labcorp (LH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$238.36 | $261.00 | $210.00 | 15.10% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Labcorp comes to $238.36. The forecasts range from a low of $210.00 to a high of $261.00. The average price target represents an increase of 15.1% from the last closing price of $207.09.
Analyst Price Targets (14)
Broker Rating
Labcorp currently has an average brokerage recommendation (ABR) of 1.66 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 16 brokerage firms. The current ABR compares to an ABR of 1.66 a month ago based on 16 recommendations.
Of the 16 recommendations deriving the current ABR, 10 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 62.5% and 6.25% of all recommendations. A month ago, Strong Buy made up 62.5%, while Buy represented 6.25%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/LH.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 10 | 10 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.66 | 1.66 | 1.66 | 1.66 | 1.66 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/15/2024 | UBS | Kevin Caliendo | Strong Buy | Strong Buy |
7/10/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
7/9/2024 | Evercore Partners | Elizabeth Anderson | Hold | Hold |
6/5/2024 | Not Identified | Not Identified | Hold | Hold |
4/26/2024 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Strong Buy |
4/26/2024 | Not Identified | Not Identified | Hold | Hold |
4/25/2024 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
4/15/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
3/25/2024 | Argus Research Corp. | Jasper Hellweg | Hold | Strong Buy |
2/26/2024 | SVB Securities | Michael Cherny | Not Available | Strong Buy |
12/1/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.66 |
ABR (Last week) | 1.66 |
# of Recs in ABR | 16 |
Average Target Price | $238.36 |
LT Growth Rate | 8.90% |
Industry | Medical - Dental Supplies |
Industry Rank by ABR | 163 of 252 |
Current Quarter EPS Est: | 3.78 |